Full name
NEUROMEDICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
27 - Manufacture of electrical equipment
62 - Computer programming, consultancy and related activities
71 - Architectural and engineering activities; technical testing and analysis
72 - Scientific research and development
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,3 | -0,4 | -1,2 | -238,4 |
Gross profit (loss) | -0,1 | -0,3 | -0,9 | -211,2 |
EBITDA | -0,1 | -0,3 | -0,2 | 17,5 |
Short time liabilities | 0,1 | 0,1 | 0,1 | 26,7 |
Other operating costs | 0 | 0 | 0 | -70,7 |
Equity capital | 1 | 0,7 | -0,2 | -126,1 |
Operating profit (EBIT) | -0,1 | -0,3 | -0,8 | -224,5 |
Assets | 2,7 | 3,3 | 2,9 | -12,3 |
Net profit (loss) | -0,1 | -0,3 | -0,9 | -211,2 |
Cash | 0,4 | 0,1 | 0,1 | 28,5 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 1,7 | 2,5 | 3 | 20,5 |
Working assets | 0,8 | 0,1 | 0,4 | 178,1 |
Other income costs | 0,2 | 0,1 | 0,4 | 223,9 |
Depreciation | 0 | 0 | 0,6 | 15 621,9 |
% | % | % | p.p. | |
Profitability of capital | -13,2 | -40,5 | 482,9 | 523,4 |
Equity capital to total assets | 37,6 | 22,3 | -6,6 | -28,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 7.048833847045898 | 2.3546969890594482 | 5.166162014007568 | 2,8 |
Net dept to EBITDA | 1.207581877708435 | -3.2807857990264893 | -6.593863010406494 | -3,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane